Microsatellite Instability Testing
The latest news on microsatellite instability testing.
Promega to Develop Microsatellite Instability Companion Diagnostic Kit With GlaxoSmithKline
The IVD kit will be used to identify patients with the MSI biomarker who may be eligible for potential treatment with GSK's Jemperli (dostarlimab-gxly).
Tempus Gains FDA Premarket Approval for NGS Solid Tumor Profiling Test
The xT CDx is a 648-gene next-generation sequencing test that can help guide treatments for colorectal cancer patients with targeted therapies.
Biocartis Nabs FDA 510(k) Clearance for Lynch Syndrome Screening Assay
The Idylla MSI Test identifies microsatellite instability in colorectal cancer tumors to aid in the identification of potential Lynch syndrome.
In new guidelines, an expert panel recommended IHC and PCR for certain cancer types and pointed out knowledge gaps supporting NGS in other settings.
Promega, Henlius to Develop Microsatellite Instability CDx for Cancer Drug
The companies aim to develop the companion diagnostic for use with Henlius' investigational treatment for microsatellite instability-high solid tumors.